Lumen Bioscience develops oral antibody therapeutics.
| Website | http://lumen.bio |
| Revenue | $12.7 million |
| Employees | 113 (96 on RocketReach) |
| Founded | 2017 |
| Technologies |
HTML
,
Nginx
,
ASP.NET
+32 more
(view full list)
|
| Industry | Biotechnology Research, Industrial biotechnology, Cyanobacteria, Pigments |
| Web Rank | 13 Million |
| Keywords | Therapeutic Antibodies, Therapeutic Proteins, Novel Therapeutics, Biopharmaceutical Development, Innovative Medicines, Drug Delivery, Advanced Therapeutics, Pharmaceutical Research, Biological Drugs, Biotechnology, Immunology, Molecular Biology, Protein Engineering, Pharmaceutical Manufacturing, Clinical Trials, Drug Discovery, Biologics |
| Competitors | Novartis, AstraZeneca, Genentech, Amgen, Moderna Therapeutics, CureVac, Zymeworks Inc., Geno, Zymergen, Inc., Evox Therapeutics Ltd +48 more (view full list) |
Looking for a particular Lumen Bioscience employee's phone or email?
The Lumen Bioscience annual revenue was $12.7 million in 2026.
Brian Finrow is the CEO and Founder of Lumen Bioscience.
96 people are employed at Lumen Bioscience.
Lumen Bioscience is based in Seattle, Washington.